Oridonin acts as a novel senolytic by targeting glutathione <i>S</i>-transferases to activate the ROS-p38 signaling axis in senescent cells

Ying Zhang, Qianyu Zhang, Zheng Chu, Lin Chen, Jiayun Chen, Yang Yang, Huan Tang, Guangqing Cheng, Ang Ma, Ying Zhang,

Chemical Communications · 2022 · 18 citations · 13 references

Concepts

Abstract

We have identified oridonin as a novel senolytic and revealed the mechanism of oridonin by covalently inhibiting a class of glutathione S-transferases (GSTs) to increase the ROS level, and activate p38 to induce apoptosis in senescent cells.

References

13